CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
ACCESS II mHealth Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04499781
NCT04499781N/ACompleted
CompareCT.gov

Adherence Connection for Counseling, Education, and Support (ACCESS) II

NYU Langone Health·interventional·Posted Aug 5, 2020·Updated Sep 24, 2025

In Brief

A clinical study evaluating ACCESS II mHealth Intervention and ACCESS II control condition for HIV Infections. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The primary objective of the proposed clinical trial, Adherence Connection for Counseling, Education, and Support (ACCESS)-II, is to test the efficacy of ACCESS-II on antiretroviral treatment (ART) adherence and HIV-viral load in Black and Hispanic HIV-infected (HIV+) adolescents and young adults (AYA), ages 18-29 years (N=120) using a longitudinal (12 and 24 week outcomes), two-group, randomized control trial (RCT). Participants in the intervention condition will use videoconferencing to connect synchronously with trained HIV+ peer health coaches who will deliver eight weekly, 60-minute cognitive behavioral/motivational sessions for improved ART adherence. Participants in the control will connect asynchronously to a web-based HIV ART adherence education condition.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUnited States
CollaboratorsJacobi Medical Center

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 5, 2020
Enrollment StartFeb 14, 2022
Primary CompletionJul 25, 2024
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 5.9 years ago

Interventions

ACCESS II mHealth Interventionbehavioral

Participants in the intervention condition will use videoconferencing to connect synchronously with trained HIV+ peer health coaches who will deliver eight weekly, 60-minute cognitive behavioral, motivational sessions for improved ART adherence.

ACCESS II control conditionbehavioral

Web-based HIV adherence education. Participants in the control group will connect asynchronously to a web-based HIV ART adherence education condition.